The Montreal Cognitive Assessment as a Screening Tool for Preoperative Mild Cognitive Impairment in Geriatric Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

582 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-01-31

Study Completion Date

2016-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a prospective, double-blinded, control trial. The Montreal Cognitive Assessment is used to screen preoperative mild cognitive impairment in 582 consecutive geriatric patients, scheduled for general, vascular or urological surgery under general and/or regional anesthesia.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Home-based Cognitive Monitoring in MCI

NCT04350801

Mild Cognitive Impairment

UNKNOWN

The "Motoric Cognitive Risk" Syndrome in the Canadian Population

NCT03679026

Cognition Disorders in Old Age Cardiovascular Diseases Dementia

ACTIVE_NOT_RECRUITING

Cognitive Prefrail and Frailty, and Motoric Cognitive Risk Syndrome: Prevalence and Association With Incident Adverse Health Events

NCT04275817

Frailty Motoric Cognitive Risk Syndrome Cognitive-prefrailty

ACTIVE_NOT_RECRUITING

Investigating Neurocognitive Disorders Epidemiology

NCT06375213

Dementia Cognitive Decline Alzheimer Disease

RECRUITING

Validation of the Montreal Cognitive Assessment in Patients With Mild and Major Neurocognitive Disorder

NCT03581643

Alzheimer Disease Mild Cognitive Impairment

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

At the preoperative visit, the co-researcher invites 322 general and vascular patients (male 190, female 132) and 260 urological patients (male 220, female 40) who meet the inclusion criteria to join the study. The process of the project is explained to the interested patients in details before an informed consent is obtained.

All participants are interviewed by using the Montreal Cognitive Assessment test. The history of drug used preoperatively (medication reconciliation) has also been recorded.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mild Cognitive Impairment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* male or female aged 65 yr, ASA I-III scheduled for elective general, vascular or urological surgery under general and/or regional anesthesia.

Exclusion Criteria

* unable to communicate in reading and writing
* psychosomatic patients
* insulin-dependant diabetes
* renal insufficiency (creatinine \>1.5 mg/dL), renal dialysis
* uncontrolled congestive heart failure (American Heart Association Classification III or IV congestive heart failure), unstable angina, untreated cardiac arrhythmia
* active gastrointestinal bleeding.

Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No